1 "방사성의약품 치료" 서울: 고려의학 767-798, 1997.
2 "방사선 안전관리" 서울: 고려의학 235-251, 1997
3 "et al. Treatment planning for internal radionuclide therapy three- dimensional dosimetry for nonuniformly distributed radionuclides. J Nucl Med. 1990" 1884-91.
4 "et al. Three dimensional dosimetry for radioimmunotherapy treatment planning. J Nucl Med. 1993" 1595-601,
5 "et al. CT SPECT fusion plus conjugate views for determining dosimetry in iodine-131-monoclonal antibody therapy of lymphoma patients. J Nucl Med. 1994" 1714-20,
6 "Zanzonico PB. AAPM report No. 17: a primer for radioimmunotherapy and radionuclide therapy" American Association of Physicists in Medicine 2001.
7 "Watson EE. MIRD primer for absorbed dose calculation. New York The Society of Nuclear Medicine" 1988.
8 "Update on hybrid conjugate-view SPECT tumor dosimetry and response in 131I-tositumomab therapy of previously untreated lymphoma patients" 44 : 457-464, 2003
9 "Roeske JC. An overview of imaging techniques and physical aspects of treatment planning in radioimmunotherapy. Med Phys. 1993" 569-77,
10 "Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non Hodgkin's lymphoma: combined data from 4 clinical trials" 44 : 465-474, 2003
1 "방사성의약품 치료" 서울: 고려의학 767-798, 1997.
2 "방사선 안전관리" 서울: 고려의학 235-251, 1997
3 "et al. Treatment planning for internal radionuclide therapy three- dimensional dosimetry for nonuniformly distributed radionuclides. J Nucl Med. 1990" 1884-91.
4 "et al. Three dimensional dosimetry for radioimmunotherapy treatment planning. J Nucl Med. 1993" 1595-601,
5 "et al. CT SPECT fusion plus conjugate views for determining dosimetry in iodine-131-monoclonal antibody therapy of lymphoma patients. J Nucl Med. 1994" 1714-20,
6 "Zanzonico PB. AAPM report No. 17: a primer for radioimmunotherapy and radionuclide therapy" American Association of Physicists in Medicine 2001.
7 "Watson EE. MIRD primer for absorbed dose calculation. New York The Society of Nuclear Medicine" 1988.
8 "Update on hybrid conjugate-view SPECT tumor dosimetry and response in 131I-tositumomab therapy of previously untreated lymphoma patients" 44 : 457-464, 2003
9 "Roeske JC. An overview of imaging techniques and physical aspects of treatment planning in radioimmunotherapy. Med Phys. 1993" 569-77,
10 "Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non Hodgkin's lymphoma: combined data from 4 clinical trials" 44 : 465-474, 2003
11 "Radiation Dosimetry" Philadelphia: W.B.Saunders Company 106-134, 1995
12 "Quantitative Imaging-Based Dosimetry and Treatment Planning in Radionuclide Therapy" Singapore: Springer 537-562, 2006.
13 "Preliminary results from intensity based CT SPECT fusion in I-131 anti-B1 monoclonal-antibody therapy of lymphoma" 80 : 2538-2544, 1997
14 "Phelps ME. editors. Physics in Nuclear Medicine. 3rd ed. Philadelphia" Philadelphia: Saunders 405-425, 2003.
15 "Patient specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody: assessment of tumor dose response" 44 : 260-268, 2003
16 "OLINDA/EXM: the second generation personal computer software for internal dose assessment in nuclear medicine" 46 : 1023-1027, 2005
17 "Monte Carlo evaluation of object shape effects in iodine-131 SPET tumor activity quantification" 28 : 900-906, 2001
18 "MIRDOSE: personal computer software for internal dose assessment in nuclear medicine" 37 : 538-546, 1996
19 "MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates" 40 : 37S-61S, 1999
20 "MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee" 40 : 11S-36S, 1999
21 "Inernal Radiation Dosimetry in Radionnuclide Therapy" 40 : 120-126, 2006
22 "Improved conjugate view quantitation of I-131 by subtraction of scatter and septal penetration events with a triple energy window method. Med Phys" 22 : 1637-1643, 1995
23 "Dosimetry of internal emitters" 46 : 18S-27S, 2005
24 "Developing and testing integrated multicompartment models to describe a single-input multiple output study using SAAM II software system" Oak Ridge, TN: Oak Ridge Associated Universities 577-599, 1999
25 "Determining total I-131 activity within a VoI using SPECT, a UHE collimator, OSEM, and a constant conversion factor" 51 : 611-618, 2004
26 "Deadtime correction for two multihead Anger cameras in 131I dual-energy- window-acquisition mode" 25 : 85-91, 1998
27 "Characterization of scatter and penetration using Monte Carlo simulation in 131I imaging" 41 : 123-130, 2000
28 "BLD - a software system for physiological data handling and model analysis" 562-5,
29 "An activity quantification method based on registration of CT and whole body scintillation camera images, with application to 131I" 43 : 972-982, 2002
30 "Accuracy of 131I tumor quantification in radioimmunotherapy using SPECT imaging with an ultra high energy collimator: Monte Carlo study" 41 : 1760-1767, 2000
31 "AMIDE: A Free Software Tool for Multimodality Medical Image Analysis" 2 : 131-137, 2003
32 "AAPM report No. 17: a primer for radioimmunotherapy and radionuclide therapy" American Association of Physicists in Medicine 2001.
33 "A 3 dimensional absorbed dose calculation method based on quantitative SPECT for radionuclide therapy: evaluation for 131I using monte carlo simulation" 43 : 1101-1109, 2002
34 "131I-Anti CD20 radioimmunotherapy of relapsed or refractory non Hodgkins lymphoma: a phase II clinical trial of a nonmyeloablative dose regimen of chimeric rituximab radiolabeled in a hospital" 18 : 513-524, 2003
국립중앙도서관 "우편 복사 서비스"로 연결 됩니다.
ScienceON
